The BWH Health & Technology Innovation Fund seeks applications for basic/clinical/translational science-focused as well as commercialization-oriented research projects from scientists and clinicians at Brigham & Women’s Hospital. The Fund is a combined venture supported by the Brigham Research Institute and the BWH Health & Technology Sub-Committee which is composed of friends of the Brigham from the philanthropic world.
The Health & Technology Innovation Grants will fund high-reward, high-impact (whether scientific or commercial) projects. Basic, clinical and translational projects that have the scientific merit and novelty to significantly advance the progress of research in their field and; research or clinical projects that have the commercialization potential to be transformed into innovative products or new services or companies or that can impact patient care at BWH are the types of projects that will be considered.
Grants will be awarded on a competitive basis with up to four non-renewable $50,000 grants available this year. Applications will be evaluated and ranked for funding priority on the basis of a strategic and scientific review. Ultimate selection will depend on input from a review committee and recommendations from the BRI Executive Committee (EC). Please note that the selection process will involve review by both BWH faculty (clinicians/researchers) as well as non-BWH reviewers including donors, venture capitalists, representatives of the biopharma/device industry and other friends of the Brigham. The final selection round will be a ’shark tank’ (live pitch session) featuring the finalists and conducted as a closed door meeting with the review committee in attendance.
|Initial Selection Process||Dates|
|RFA announcement||December 16, 2016|
|Letter of intent due||January 25, 2017|
|Full applications invited||February 15, 2017|
|Full applications due/Notify Partners Innovation||March 29, 2017|
|Finalists selected and notified/Send materials to reviewers at live pitch session and assign ‘champions’||April 26, 2017|
|Finalists prep session||3:00-4;00 pm, May 4, 2017|
|‘Shark Tank’ (Live pitch session) – Review committee will be composed of BWH clinicians and researchers, Partners Innovation staff as well as non-BWH reviewers including donors, venture capitalists, representatives of the biopharma/device industry and other friends of the Brigham.||To Be Determined
|Funding start date||To Be Determined|
Letters of intent (due January 25, 2017 12:00pm) should be submitted online and will include the following:
Click here to submit the LOI: http://bwhcfdd.partners.org/Listing.aspx?courseId=282
Invited full applications (due March 29, 2017, 10:59pm) should be submitted online (submission link will be provided to invited applicants) and must include the following:
By applying for the BWH Health & Technology Innovation Fund Grants, you agree to release and hold harmless BWH, the Health & Technology Innovation Fund and its subsidiaries, affiliates, societies, advertising and promotion agencies, partners, representatives, agents, successors, assigns, employees, officers and directors from any liability, illness, injury, death, loss, litigation, claim or damage that may occur, directly or indirectly, whether caused by negligence or not, from such Applicant’s participation in the BWH Health & Technology Innovation Fund Grant competition and/or his/her acceptance, possession, use, or misuse of any award or any portion thereof.